- Todos > Medicine Access and Rational Use > Supply Management
- Todos > Quality and Safety: Medicines > Quality Assurance
- Todos > WHO Prequalification of Medical Products > WHO-UNICEF-UN Project
- Palabras clave > Good Procurement Practices (GPP)
- Palabras clave > inspection
- Palabras clave > Model Quality Assurance System (MQAS)
- Palabras clave > prequalification of medicines
- Palabras clave > procurement agencies - quality assurance system
- Palabras clave > quality assurance - purchasing
- Palabras clave > quality assurance system
(2014; 72 pages) [French]
The Expert Committee on Specifications for Pharmaceutical Preparations of the World Health Organization (WHO) adopted a Model quality assurance system for procurement agencies (MQAS) during a meeting in Geneva, Switzerland in 2005. This was subsequently published as Annex 6 in the Technical Report Series, No. 937 in 2006. Some procurement organizations have implemented the recommendations presented in the MQAS. Some donor organizations (including the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)) have endorsed the MQAS as part of their quality assurance policy for the procurement of pharmaceutical products with their funds. Several organizations have also prepared a tool to assess procurement agencies to establish the level of implementation and compliance with the MQAS...
Since the first publication of the MQAS and its use by many organizations, it appeared that a revision would be timely and could include current developments. During its forty-eighth meeting, the WHO Expert Committee on Specifications for Pharmaceutical Preparations adopted the updated MQAS together with the replacement texts for Appendix 6 Interagency finished pharmaceutical product questionnaire and Appendix 14 Guidance on good manufacturing practices: model inspection report. In addition, the aide-memoire was recommended for use and is published as Annex 4 in the report of the fortyeighth Expert Committee meeting (WHO Technical Report Series, No. 986).